BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8286822)

  • 1. Enalapril-induced hepatotoxicity.
    Valle R; Carrascosa M; Cillero L; Perez-Castrillon JL
    Ann Pharmacother; 1993 Nov; 27(11):1405. PubMed ID: 8286822
    [No Abstract]   [Full Text] [Related]  

  • 2. Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.
    Hagley MT; Benak RL; Hulisz DT
    Ann Pharmacother; 1992 Jun; 26(6):780-1. PubMed ID: 1611160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enalapril (Reniten)-associated toxic hepatitis].
    Hürlimann R; Binek J; Oehlschlegel C; Hammer B
    Schweiz Med Wochenschr; 1994 Jul; 124(29):1276-80. PubMed ID: 8066414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatitis after taking enalapril maleate (Renitec)].
    Lunel F; Grippon P; Cadranel JF; Victor N; Opolon P
    Gastroenterol Clin Biol; 1987 Feb; 11(2):174-5. PubMed ID: 3032724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enalapril induced cholestasic hepatitis].
    Muela Molinero A; Linares Torres P; Domínguez Carbajo AB; Olcoz Goñi JL
    An Med Interna; 2002 Sep; 19(9):492-3. PubMed ID: 12420643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatoxicity by enalapril].
    Quílez C; Palazón JM; Chuliá T; Córdoba YC
    Gastroenterol Hepatol; 1999 Feb; 22(2):113-4. PubMed ID: 10193097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreatitis and hepatitis in a patient treated with enalapril maleate. A case report].
    Martin T; Taupignon A; Graf E; Perrin D
    Therapie; 1989; 44(6):449-50. PubMed ID: 2560267
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal hepatotoxicity associated with enalapril.
    González de la Puente MA; Calderón E; Espinosa R; Rincón M; Varela JM
    Ann Pharmacother; 2001 Nov; 35(11):1492. PubMed ID: 11724106
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic injury related to enalapril.
    Rosellini SR; Costa PL; Gaudio M; Saragoni A; Miglio F
    Gastroenterology; 1989 Sep; 97(3):810. PubMed ID: 2546851
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute hepatotoxicity caused by enalapril: a case report.
    da Silva GH; Alves AV; Duques P; Sevá-Pereira T; Soares EC; Escanhoela CA
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):187-90. PubMed ID: 20593053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic hepatitis with captopril but not with enalapril.
    Zannad F; Marie PY; Aliot E; Trechot P; Gilgenkrantz JM
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):669-70. PubMed ID: 2856462
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
    Savenkov MP; Ivanov SN; Brodskaia SA
    Ter Arkh; 2001; 73(9):27-31. PubMed ID: 11642076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
    Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
    J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment: angiotension-converting enzyme inhibitor hepatotoxicity: further insights.
    Hilburn RB; Bookstaver D; Whitlock WL
    Ann Pharmacother; 1993 Sep; 27(9):1142-3. PubMed ID: 8219456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver damage following antihypertensive therapy. A case report of hepatitis induced by lisinopril and a review].
    Lindgren A; Olsson R
    Lakartidningen; 1993 Apr; 90(16):1557-8. PubMed ID: 8387127
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of patch tests for diagnosing selective allergy to captopril.
    Gaig P; San Miguel-Moncin MM; Bartra J; Bonet A; García-Ortega P
    J Investig Allergol Clin Immunol; 2001; 11(3):204-6. PubMed ID: 11831455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC; Plevris JN; Bouchier IA
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.